Do not stop or change your medication without speaking to a pharmacist or healthcare professional.
Permanently Discontinued

AVAPRO

SANOFI-AVENTIS CANADA INC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is AVAPRO discontinued in Canada?

Yes. The manufacturer has reported to Health Canada that AVAPRO 75MG has been permanently discontinued (last updated January 15, 2025). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.

Can I still get this?Possibly — same-ingredient product records found
StatusPermanently Discontinued
Same-ingredient products on file6 products
Affected strength75MG
Report last updated2025-01-15
Checked by MedShort2026-11-13

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

IRBESARTAN

SANIS HEALTH INC

75MG · DIN 02372347

Same strengthSame dosage formSame routeNo current shortage

SPC-IRBESARTAN

SUN PHARMA CANADA INC

75MG · DIN 02406810

Same strengthSame dosage formSame routeNo current shortage

PRO-IRBESARTAN

PRO DOC LIMITEE

75MG · DIN 02365197

Same strengthSame dosage formSame routeNo current shortage

Other Products

AVAPRO

SANOFI-AVENTIS CANADA INC

300MG · DIN 02237925

Different strengthSame dosage formSame routeNo current shortage

MINT-IRBESARTAN

MINT PHARMACEUTICALS INC

150MG · DIN 02422999

Different strengthSame dosage formSame routeNo current shortage

PMS-IRBESARTAN

PHARMASCIENCE INC

300MG · DIN 02317087

Different strengthSame dosage formSame routeNo current shortage

What this means

Does this mean I need to switch medications right away?

Not necessarily right away, but this product will not be returning to the market.

What should I do?

Talk to your pharmacist or prescriber about your options well before your current supply runs out.

DIN

02237923

Strength

75MG

Dosage Form

TABLET

Route

ORAL

Active Ingredient

IRBESARTAN

See all IRBESARTAN products →

Shortage History